Albert B. Sabin Vaccine Institute, Inc. (The) lands $145M Health and Human Services contract in Washington, D.C.

Contract News Wire · 2026-09-20 · Albert B. Sabin Vaccine Institute, Inc. (The) profile →

Albert B. Sabin Vaccine Institute, Inc. (The) has been awarded a contract worth $145M by the Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response), with work to be performed in Washington, D.C..

According to the award record, the contract covers: “This contract is to advance the development of monovalent vaccines for prevention of marburg virus (marv) and sudan ebolavirus (sudv) disease.”

Sub-Op Radar: awards of this type frequently create near-term opportunities for research partners, lab suppliers, and specialized fabricators. Primes typically begin sourcing shortly after award.

Period of performance begins 2019-09-26 and runs through 2027-09-30. Award ID: 75A50119C00055. Source: USAspending.gov.

Is this your company? Claim the Albert B. Sabin Vaccine Institute, Inc. (The) profile — free

Work in Washington, D.C.? Get tomorrow's awards in your inbox — daily, filtered to your states